Skip to content

Remote Monitoring Using a Digital Platform

RecruitingNot applicableNCT07837102
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

A single site, proof-of-concept prospective behavioral interventional study testing remote monitoring among people living with chronic pain. The study is a single arm study. The duration of the study will be 12-18 months, enrolling 100 and following up to six months post enrollment/ baseline. A convenience sample of 50 patients with CP meeting the inclusion criteria will participate in a 3 to 6 month remote monitoring program utilizing FitCam. Since the time period to conduct this study is 12 months. FitCam portal/ app will be utilized for the intervention and the outcome will be recorded to observe if remote monitoring has an affect in the health outcome compared to baseline health quality of the patient.

Study details

Official title
Optimizing Chronic Pain Management Through Remote Monitoring: A Proof-of-Concept Study Using a Digital Platform
Conditions
Interventions
  • Behavioral: Remote application intervention
Sponsor
Hackensack Meridian Health
Collaborators
New Jersey Health Foundation
Start date
2025-12-18
Primary completion
2028-02-10
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Signed informed consent form (ICF) * Age: Adults aged 18 years or older * Ability to comply with the study protocol, including having a smartphone and being able and willing to access the application on a regular basis. To use all functionalities of the application, the user's smartphone must comply with the minimum system requirements (Android version 8.0 or above, iOS version 13.0 or above) * Have a valid email address * Have a valid phone number * Diagnosis Codes: * Patients with a confirmed diagnosis of Chronic Pain Syndrome based on ICD-10 code G89.4 as primary diagnosis. ■ Including Fibromyalgia M79.7 * Patient with a confirmed secondary diagnosis * Back Pain M54.5 * Neck Pain M54.2 * Joint Pain M25.5 * Medications: N/A * Test/Lab results: N/A * Study sites: Hackensack Meridian Health Neuroscience Institute located at 650 From Road, Suite 506, Paramus, NJ, 07652 * Service: Outpatient Exclusion Criteria: * Age: Patients below 18 years of age * Unable or unwilling to provide informed consent * Presence of an active diagnosis of a comorbid cognitive impairment such as dementia or mild cognitive impairment * Lack of access to a smartphone device or inability to demonstrate proficiency in downloading and using mobile applications * Physical limitations that prevent participation in a basic home exercise program * Considered by the investigator to have a condition that precludes safe or active participation in the trial

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07837102